Measurement of pacemaker performance by Preston, Thomas A. et al.
Thomas A. Preston, B.S.E.E., M.D.* 
Richard D. Judge, B.S.E.E., M.D.** 
David L. Bowers, B.S.E.E.*** 
Joe D. Morris, M.D.**** 
Ann Arbor, A&h. 
mhis report concerns a simple method 
1. of assessing pacemaker function by 
externally analyzing its signal. The method 
has proved to be of practical value, not 
only in monitoring pacemaker performance 
after implantation, but also in identifying 
the cause of “failure” when and if it oc- 
curs. Satisfactory treatment of complete 
heart block with electronic pacemakers 
has been complicated by an inability to 
measure pacemaker function after im- 
plantation. The duration of artificial pac- 
ing is limited by the “life” of the individual 
unit, and when it fails, reimplantation 
of a new pacemaker is usually mandatory. 
Routine replacement of each pacemaker, 
after 15 months of service, has been recom- 
mended as one method of assuring a high 
probability of trouble-free perf0rmance.r 
Such prophylactic replacement is reason- 
able in the absence of adequate knowledge 
of pacemaker function after implantation, 
since the only alternative is for the phy- 
sician to await failure before recommend- 
ing replacement, thus incurring the risk 
of untreated complete heart block during 
the interim period. 
Two major problems can be identified 
in the long-term management of pace- 
maker patients: first, uncertainty of when 
a pacemaker will fail ; and second, accurate 
information about the cause for pace- 
maker failure if it occurs unexpectedly. 
The former is not only medically important 
for the protection of the individual pa- 
tient, but economically important for 
assurance of full use of the pacemaker 
prior to replacement. The latter is also 
vital, since the management of different 
types of pacemaker “failures” varies, 
depending on the cause.2-6 The method 
to be described enables the physician to 
answer both of these vital questions. 
Although this method is applicable to 
only one of the commercially available 
units? at the present time, the problems 
of management are common to all artificial 
pacemakers. 
Materials ad mews 
This study consisted of three phases 
of investigation. During the first phase, 
in order to analyze the exact shape and 
magnitude of the pacemaker waveform, 
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Fig. la, Oscilloscopic picture of pacemaker pulse 
waveform, showing sudden onset, RC decay, and 
abrupt termination. From onset to termination 
is the pulse width. b, Detector-coil stimulus de- 
flections, coinciding with beginning and end of 
pacemaker pulse. Note that the onset deflection is 
greater than the termination deflection, due to 
greater change in current. 
measurements of voltage between the 
myocardial electrodes were made from a 
series of 4 dogs with external pacemakers. 
This was done by using a calibrated, 
cathode-ray oscilloscope (Tektronic, type 
502), capable of pulse synchronization 
and having a sweep of 1 millisecond per 
centimeter. Fig. 1,a shows a photograph 
of the voltage of a pacemaker pulse as 
seen on the oscilloscope. Multiple measure- 
ments were made on each animal, and were 
recorded by means of a Polaroid camera. 
To measure current, a l-ohm resistance 
was inserted in series with the heart im- 
pedance, and by the same method the 
voltage across this resistance was meas- 
ured. The voltage value thus obtained 
is equivalent to current. Total pulse energy 
was then calculated from these two curves 
by multiplying average voltage times 
average current for each millisecond 
throughout the pulse, and integrating 
the millisecond decrements of energy for 
the duration of the pulse. 
Investigation showed that the pulse 
duration, or pulse width, can be exactly 
measured by placing a detector coil (7,000 
turns of No. 38 magnet wire) on the surface 
of the skin over the pacemaker unit. Fig. 
1 ,b shows oscilloscopic measurement of 
the pulse width. It is the distance between 
the two deflections, due to voltages in- 
duced in the detector coil by the rapidly 
changing currents during the upstroke 
and downstroke of the pacemaker pulse. 
The upstroke of the pulse represents a 
greater rate of change in current than 
does the downstroke, and therefore induces 
in the detector coil a greater voltage. The 
two deflections correspond exactly to the 
onset and termination of the pacemaker 
pulse. 
The third phase of the investigation 
was the application of these methods to 
the human heart. The first step was to 
make direct measurements of voltage and 
current from the external pacemaker elec- 
trodes of one patient, in order to be sure 
that there were no significant differences 
between canine and human cardiac im- 
pedances. Then, two pacemakers were 
carefully precalibrated (rate and pulse 
width determined for a range of biologic 
impedances), after which they were im- 
planted into patients. Serial measurements 
were made of exact pacemaker rate and 
pulse width, using the detector method. 
This was done externally, by placing the 
detector coil over the implanted pace- 
maker. Finally, we applied these methods 
to a clinical series of 42 patients whose 
pacemakers were not specially calibrated 
for all possible impedances. 
Results 
The second phase of the investigation The studies in dogs showed that an 
was the construction of a laboratory model average interelectrode impedance was about 
with a simulated interelectrode impedance 300 ohms resistance and 47 microfarads 
identical to the “biologic” impedance as capacitance. Interelectrode impedance 
calculated from the dog studies. This measured from the human heart was not 
model allowed precise variation of load significantly different. Total output of pace- 
impedance and battery voltage so as to maker pulse energy in dogs averaged 60 
simulate all possible clinical conditions, 
with measurement of pacemaker voltage 
and current using the method described 
above. It was found that, for any biologic 
impedance, an equivalent electrical re- 
sistance and capacitance could be sub- 
stituted. 
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microjoules. In the one patient in whom it 
was measured, the pulse energy \vas 67 
microjoules. 
The pacemaker used in this study has 
a resistance-capacitance (RC) discharge 
waveform as show-n in Fig. 1,~. Any bio- 
logic load can be replaced by an indis- 
tinguishable simulated load of resistance 
(RL) in series with capacitance (CL), 
as shown in Fig. 2. Using variable simu- 
Fig. 2. Schematic representation of pacemaker 
interelectrode, or myocardial impedance. RL (load 
resistance) and CL (load capacitance) are in series 
with the pacemaker electrodes. 
lated interelectrode impedances (1~ ,, anti 
(‘I,), and vaqing I)at ter\. voltage. ux 
found that changes in an!. oi these three 
parameters were reflected by measurable 
changes in one or both of t\\-o clinicall!. 
obtainable variables, pacemaker rate and 
pulse width. EspecialI!. noten-orthq- was 
the finding that a cl1ang.e in RI, caused a 
measurable change in pulse u.idth, its 
shown in Fig. 4. Varying RI. did not change 
pulse rate until RI, exceeded 5,000 ohms. 
In all animal and human measurements, 
Rr, was in the range of 200 to 500 ohms, 
provided that the pacemaker \vas func- 
tioning normally. We never observed it to 
exceed 500 ohms. Therefore, it could be 
concluded that biologic increases in RF. 
do not affect the pacemaker rate. 
Changes in Cr,, on the other hand, 
caused a proportionate change in pulse 
width, and an inverse change in pacemaker 
rate. Fortunately, changes in pulse width 
were mininlnl and nithin the litnit of 
error of the method (1, 10 millisecond). 
Changes in rate, however, were ver)- sig- 
nificant when (1,. varied nithin the ob- 
served biologic range. A variation of 20 
microfarads produced a detectable vari- 
ation in rate of 3 pulses per nlinute in the 
range of the average biologic value of CL 
(47 microfarads). See Fig. 3. 
Infer-elmtnM0 apachce, CL inpf 
Fig. 3. CL versus pulse period in milliseconds. The pulse period is the time betweelx pulses. Approximate rates 
are shown in parentheses. In the example shown. a rate of 86 gives a Cr, of 10 microfarads. 
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Inter-e!ectroda resistance, RLin ohms 
Fig. 4. RL versus pulse width. In the example shown, for CL = 10, a pulse width of 6.0 gives RL = 300 ohms. 
Changes in battery voltage also affected 
both rate and pulse width, but to an equal 
degree. A decrease of 7 per cent (0.5 volt) 
in the voltage of the main battery resulted 
in a 3.5 per cent increase in rate (2 pulses 
per minute), and at the same time caused 
a 4 per cent increase in pulse width (0.3 
millisecond). These changes pertain only 
if the bias battery remains constant. A 
decrease in the voltage of the bias battery 
results in a decrease in rate and no change 
in pulse width. 
Application of these observations to the 
practical problem of monitoring pacemaker 
function resulted in the following deduc- 
tions: (1) An isolated increase in pulse 
width, with no change in rate, denotes a 
predictable increase in interelectrode re- 
sistance. (2) An i’solated decrease in rate 
with no change in pulse width denotes a 
predictable increase in interelectrode ca- 
pacitance. (3) Progressive, simultaneous 
increases in both pulse width and rate 
most likely represent a decreasing voltage 
of the main battery. Although this combi- 
nation could be simulated by an increase 
in RI, with a concomitant decrease in CL, 
subsequent clinical observations proved 
that this possibility was unlikely. (4) 
Abrupt, sizable increases in rate and pulse 
width, with or without variations from 
one pulse to the next, cannot be accounted 
for by biologic variations in RL and CL, 
and therefore can only be produced by a 
lead fracture, which would suddenly intro- 
duce a marked change in both RL and CL. 
Subsequent experience showed that the 
open circuit produced by an electrode 
break is frequently bridged by an imped- 
ance which may be variable, causing 
changes in RI, and CL from one pulse to 
the next. 
Fig. 5. RL and CL versus time for 2 patients with 
precalibrated pacemakers. Note the rise in RL, 
while Cr. becomes constant after the postoperative 
period. 
Application of these principles to the 
human problem began by our making 
serial measurements of rate and pulse 
width on 2 patients whose implanted pace- 
makers had been precalibrated by de- 
termining rate and pulse width for various 
values of RI, and Cr, within biologic limits. 
The values of these two variables were 
determined over a period of 6 months, 
and are shown in Fig. 5. Note that ca- 
pacitance varies insignificantly after im- 
plantation, whereas resistance tends to 
plateau after an initial rise. 
JIeasurements were also made on a 
total of 42 patients whose pacemakers 
were not precalibrated. In 19 of these, 
serial measurements were made from the 
day of implantation; in 10, serial measure- 
ments were made beginning 1 month or 
more after implantation; and in 13, only 
one measurement was made. See Table I. 
Discussion 
There is general concern that the elec- 
trochemical effect of implanted cardiac 
pacemakers on the tissue surrounding 
the electrodes, and on the myocardium 
between them, may ultimately alter pace- 
maker performance. After direct implanta- 
tion of electrodes, the interelectrode imped- 
ance, with its resultant effect on myo- 
cardial threshold, has been shown to be 
altered by at least three factors: (1) the 
type of electrodes, (2) the pulse waveform, 
and (3) foreign-body reaction around the 
electrodes.7-10 The results of this study 
show that interelectrode impedance does 
vary with time, in a predictable manner. 
Other investigators have made analyses 
of electrical signals coming from implanted 
pacemakers, but these methods have not 
given definite information of diagnostic 
value about interelectrode impedance or 
changes in pacemaker performance.llJz 
The key to this method of analysis lies 
in the circuit design of this particular 
pacemaker, \\Thich has an output pulse 
that is dependent on the load. The entire 
electrical analysis can be performed ex- 
ternally in less than 1 minute, without 
directly touching the skin of the patient, 
and absolutely without harm. For this 
reason it should have practical, clinical 
value. 
In determining interelectrode impedance 
by this method, n-e assume that batter) 
voltage remains constant throughout I he 
period of observation. We think that this 
is valid for three reasons. (1) The pace- 
maker power supply has been shown io 
reach a constant mercury voltage level, 
after which there is insignificant variation 
until the battery energy is near depletion. 
For the pacemakers used in this series, 
quality control requires constant output 
voltage for at least 3 months prior to 
implantation. (2) Serial measurements on 
five pacemakers incubated at 37°C. over 
a period of 3 years demonstrated no sig- 
nificant changes until one of the component. 
batteries had reached the end of its life. 
(3) The rates of implanted pacemakers 
have been observed to be unexpectedly 
constant after the immediate rccoverl 
period. This means that voltage must 
also be constant, since the two are inter- 
dependent. 
For a calibrated pacemaker, impedance 
is determined as follows: First, the rate 
is measured accurately, and from this rate 
the interelectrode capacitance is obtained 
from a plotted graph of CL versus rate 
(see Fig. 3). Once CL is known, RL can 
then be determined from a graph of Rr, 
versus pulse width for various values of 
CT, (see Fig. 4). The results show that 
pacemaker rate becomes constant within 
the first 6 n,eeks; therefore, interelectrode 
capacitance must become constant. The 
serial measurements after implantation, 
in 19 patients with uncalibrated pace- 
makers, showed a uniformly rising pulse 
width with constant rate. This indicates 
that the interelectrode resistance in all 
of these patients (in addition to the 2 pa- 
tients with calibrated pacemakers) in- 
creased during the first 3 months after 
implantation. I-lowever, serial measure- 
ments in 10 cases, beginning at least 3 
months after implantation, showed no 
further increases in pulse width. This 
leads to the conclusion that after 3 months 
Rr, remains constant, or nearly so. The 
near-linear increase in RI, during the first 
3 months after implantation can be at- 
tributed to changes at the electrode sur- 
faces (electrolysis), in addition to fibrosis 
in the area surrounding the electrodes. 
Changes in pacemaker performance re- 
sult in definite and distinct changes in the 
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two pacemaker variables, pulse width and 
rate. The immediate value of these findings 
is in the differential diagnosis of “pace- 
maker failures,” and in identifying incipient 
failures. Fortunately, with the pacemaker 
used there have been no component fail- 
ures. Therefore, our clinical experience 
has been concerned solely with differenti- 
ating between battery failure, electrode 
fracture, and critical elevation of myo- 
cardial threshold. 
Battery failure was correctly diagnosed 
by this method in all of 8 cases. Of par- 
ticular importance is the fact that failure 
in 5 cases was detected while the myo- 
cardium was still responding to the stimu- 
lus. The other 3 cases presented after the 
stimulus level had fallen below threshold, 
and the heart was no longer responding 
to the pacemaker. In 4 of these cases the 
main batteries were involved, and a pro- 
gressive increase in both pacemaker rate 
and pulse width was manifest. (See Table 
II.) The other 4 cases involved failure of 
the bias battery, which resulted in de- 
creasing rate without a change in pulse 
width. Each pacemaker has one bias 
battery which controls switching, and 
deterioration of this battery has the above- 
mentioned effect, which is easy to identify. 
Electrode breaks were correctly diag- 
nosed in all of a total of 5 cases, and in an 
additional unit the diagnosis of short 
circuit of the electrodes was made. A short 
circuit is manifested by a very short pulse 
Table II. Diflerential diagnosis of “pace- 
maker fu&ures,” based on changes in pace- 
maker rate and pulse w&h 
Pacemaker 





















width and a constan 1. rate. The 5 instances 
of wire breakage resulted in sudden in- 
creases in pacemaker rate, and measure- 
ments sho\ved veq’ long and variable 
pulse widths, in addition to variation i11 
rate from one pulse to the next. These 
changes are caused by an open circuit, 
giving a greatly increased and variable 
interelectrodc resistant-e (greater than 5,000 
ohms). 
Increased myocardial threshold, to a 
level above the constant-energy pacemaker 
stimulus, was diagnosed in 11 cases. In 7 
of the cases the diagnosis was confirmed 
by testing the removed pacemaker unit 
and tinding it to be functioning within 
normal limits, and in 4 cases it has not 
been necessary to replace the pacemaker. 
We have applied the term “exit block” 
to this situation. The definition given for 
exit block is “inabilit\p of an impulse to 
leave its point of ori&, the mechanism 
for jvhich is conceived as an encircling 
zone of refractory tissue denying passage 
to the emerging inipulse.“llS We think that 
this term characterizes the clinical situa- 
tion in which the Inyocardium becomes 
unresponsive to a normally functioning 
pacemaker. In our experience, the diag- 
nosis can be anticipated by finding a rising 
pulse width \vith a constant pacemaker 
rate. This indicates a rapidly rising inter- 
electrode resistance. There w:as no correla- 
tion of exit block with high absolute values 
of interelectrode resistance, but there was 
a definite correlation with rapidly increas- 
ing RL for any given patient. 
We think that, by serial measurements 
after implantation, pacemaker performance 
can be adequately evaluated so as to make 
prophylactic replacement of the unit un- 
necessary. Although electrode breaks can- 
not be identified until after a complete 
fracture occurs, and may always be an 
unpredictable factor, there is hope that 
improvements in the design of electrodes 
will drasticallv reduce the incidence of 
this type of failure. Each of our patients 
is now asked to record daily his pace- 
maker rate, using a transistor radio held 
over the unit, and he is instructed to 
report immediately any change in rate 
greater than 3 pulses per minute. Each 
patient is also asked to attend a pace- 
maker clinic \\%ich is held every 3 months, 
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for the purpose of taking serial measure- 
ments. The method of analysis described 
requires only the instruments mentioned, 
the type pacemaker used in this study, 
and an adequate knowledge of the pace- 
maker circuit.14 
Summary 
Entirely satisfactory treatment of com- 
plete heart block has been prevented by 
an inability to measure pacemaker func- 
tion after implantation. Two major prob- 
lems can be identified in the long-term 
management of pacemaker patients: first, 
adequate prediction of when a pacemaker 
will fail; and second, accurate diagnosis 
of the type of pacemaker failure if it occurs. 
Observations on dogs gave precise meas- 
urements of interelectrode impedances. A 
method is described of externally meas- 
uring the interelectrode resistance and 
capacitance of implanted pacemakers. In 
studies on both dogs and human beings 
it was found that all changes in interelec- 
trode impedance could be identified by 
changes in pacemaker rate and pulse 
width. Serial measurements of these two 
parameters allowed accurate diagnosis of 
the different types of “pacemaker failures.” 
The method also enabled anticipation of 
failures, other than wire breakage, before 
they were clinically evident, We think 
that pacemaker performance can be ade- 
quately evaluated by this method, making 
unnecessary prophylactic replacement of 
the unit. 
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